Program Description

The Carolina Cancer Nanotechnology Training Program is a 24 to 36 month National Cancer Institute–sponsored T32 postdoctoral training program offered at the UNC Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill. The overarching goal of the CCNTP is to equip a cohort of outstanding young scientists with the multidisciplinary concepts and skills needed to improve cancer diagnosis and therapy based on concepts, tools and discoveries made in nanoscience and nanotechnology. These young scientists will successfully pursue careers in academia, industry, and government agencies, and they will become significant contributors to addressing emerging challenges in public health and medical research using nanotechnology to diagnose and treat cancer.

Each trainee’s research will be co-mentored by a physical scientist and a biomedical scientist, providing a unique multifaceted training experience leading to significant contributions to cancer nanotechnology. Additionally, trainees will participate in workshops and courses that will broaden their knowledge and conceptual understanding of all areas of cancer nanotechnology. The topics of these workshops will reflect many of the major themes of the Alliance for Nanotechnology in Cancer.

This Program is Currently Accepting Applications.


Upcoming Workshops

CCNTP is hosting a workshop titled Targeted Delivery to the Tumor Microenvironment that will be held at UNC October 14-17, 2019 from 1-5pm each day. Workshop content will focus on mechanisms to deliver therapeutic agents to tumors, and the workshop will combine didactic lectures with case study discussion and primary literature analysis. The workshop is open to CCNTP T32 fellows and other interested postdocs and graduate students.

The list of speakers includes:
• Aaron Anselmo, PhD – therapeutic microbes
• Elena Batrakova, PhD – exosomes
• Yevgeny Brudno, PhD – refillable drug depots
• Yanguang Cao, PhD – antibodies
• Dirk Dittmer, PhD – viruses
• Shawn Hingtgen, PhD – stem cells
• Sasha Kabanov, PhD, DSci – polymeric micelles
• Sam Lai, PhD – nanoparticles
• Rihe Liu, PhD – high affinity ligands for cancer cells
• Colette Shen, MD – stereotactic radiosurgery
• Andy Wang, MD – nanoparticle vectors

The Carolina Cancer Nanotechnology Training Program and the University of North Carolina at Chapel Hill are committed to the principles of diversity and equal opportunity and are particularly interested in receiving applications from a broad spectrum of people, including minorities, protected veterans, and individuals with disabilities.

The Carolina Cancer Nanotechnology Training Program is committed to providing reasonable accommodations. Individuals with disabilities seeking additional information about services available on the UNC campus may visit these sites: